glp-1 regulations Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation GLP-1 medications safe to continue

This hereditary cancer risk was present since birth, and there was very little if anything the patient could have done differently throughout their life to prevent their diagnosis

Hou Y, Ernst SA, Heidenreich K, Williams JA

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications initially designed to treat type 2 diabetes but have since gained recognition for their ability to support significant weight loss

GLP's effects appear agnostic to SUD diagnosis or substance

Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations, the ability to obtain, maintain and enforce patent protection, whether patent applications will issue or claims will be allowed, clinical and regulatory development timelines, potential indications, safety and efficacy, and market opportunity